141 related articles for article (PubMed ID: 37100898)
1. Analgesics can affect the sensitivity of temozolomide to glioma chemotherapy through gap junction.
Zhang S; Guo S; Yu M; Wang Y; Tao L; Zhang X
Med Oncol; 2023 Apr; 40(6):162. PubMed ID: 37100898
[TBL] [Abstract][Full Text] [Related]
2. Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43‑mediated gap junction intercellular communication.
Wang L; Peng Y; Peng J; Shao M; Ma L; Zhu Z; Zhong G; Xia Z; Huang H
Int J Oncol; 2018 Jan; 52(1):295-304. PubMed ID: 29115581
[TBL] [Abstract][Full Text] [Related]
3. Tramadol and flurbiprofen depress the cytotoxicity of cisplatin via their effects on gap junctions.
He B; Tong X; Wang L; Wang Q; Ye H; Liu B; Hong X; Tao L; Harris AL
Clin Cancer Res; 2009 Sep; 15(18):5803-10. PubMed ID: 19723651
[TBL] [Abstract][Full Text] [Related]
4. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide.
Yang ZJ; Zhang LL; Bi QC; Gan LJ; Wei MJ; Hong T; Tan RJ; Lan XM; Liu LH; Han XJ; Jiang LP
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649836
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
6. AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes.
Zhang S; Gong Y; Wang H; Li Z; Huang Y; Fu X; Xiang P; Fan T
J Cell Mol Med; 2021 Apr; 25(8):4062-4072. PubMed ID: 33609076
[TBL] [Abstract][Full Text] [Related]
7. Propofol depresses cisplatin cytotoxicity via the inhibition of gap junctions.
Zhang Y; Wang X; Wang Q; Ge H; Tao L
Mol Med Rep; 2016 Jun; 13(6):4715-20. PubMed ID: 27082707
[TBL] [Abstract][Full Text] [Related]
8. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
9. The alpha2-adrenoreceptor agonist dexmedetomidine protects against lipopolysaccharide-induced apoptosis via inhibition of gap junctions in lung fibroblasts.
Zhang Y; Tan X; Xue L
Biochem Biophys Res Commun; 2018 Jan; 495(1):92-97. PubMed ID: 29101030
[TBL] [Abstract][Full Text] [Related]
10. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
11. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway.
Yang C; He L; Chen G; Ning Z; Xia Z
Hum Cell; 2019 Jan; 32(1):41-50. PubMed ID: 30426452
[TBL] [Abstract][Full Text] [Related]
12. Pattern of cell-to-cell transfer of microRNA by gap junction and its effect on the proliferation of glioma cells.
Peng Y; Wang X; Guo Y; Peng F; Zheng N; He B; Ge H; Tao L; Wang Q
Cancer Sci; 2019 Jun; 110(6):1947-1958. PubMed ID: 31012516
[TBL] [Abstract][Full Text] [Related]
13. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway.
Hu YH; Jiao BH; Wang CY; Wu JL
CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
Fiveash JB; Gillespie GY; Oliver PG; Zhou T; Belenky ML; Buchsbaum DJ
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):507-16. PubMed ID: 18474311
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone and levetiracetam reduce hetero-cellular gap-junctional coupling between F98 glioma cells and glial cells in vitro.
Ismail FS; Moinfar Z; Prochnow N; Dambach H; Hinkerohe D; Haase CG; Förster E; Faustmann PM
J Neurooncol; 2017 Feb; 131(3):469-476. PubMed ID: 27848138
[TBL] [Abstract][Full Text] [Related]
16. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
Fei YQ; Shi RT; Zhou YF; Wu JZ; Song Z
Neurochem Int; 2022 Jul; 157():105348. PubMed ID: 35490896
[TBL] [Abstract][Full Text] [Related]
17. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
Wei Y; Duan S; Gong F; Li Q
Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905
[TBL] [Abstract][Full Text] [Related]
18. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C
Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
Xu JX; Yang Y; Zhang X; Luan XP
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
[TBL] [Abstract][Full Text] [Related]
20. Lipidated connexin mimetic peptides potently inhibit gap junction-mediated Ca
Cotter ML; Boitano S; Vagner J; Burt JM
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C141-C154. PubMed ID: 29631365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
